RADL3 Share Price Performance
R$22.88
-3.14 (-12.07%)
4.3% undervalued intrinsic discount
R$23.92
Fair Value
Price R$22.88
AnalystConsensusTarget R$23.92
AnalystLowTarget R$14.50
AnalystHighTarget R$31.00
Fair ValueR$23.92
Share Pricen/a
Raia Drogasil S.A. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
RADL3 Community Narratives
AN
Fair Value R$23.92 4.3% undervalued intrinsic discount
RADL3: Aging Population And Digital Transformation Will Lift Retail Performance
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
Fair Value R$14.5 57.8% overvalued intrinsic discount
Accelerating E-Commerce Shift And Rapid Expansion Will Compress Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value R$28.54 19.8% undervalued intrinsic discount
Digital Momentum And Demographic Shifts Will Drive Retail Health Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
RADL3: Aging Population And Digital Transformation Will Lift Retail Performance
Key Takeaways Structural shifts in healthcare demand, digital investments, and targeted store expansion are driving market leadership, resilient sales growth, and operational efficiency gains. Enhanced automation, data-driven processes, and category mix improvements are supporting higher margins, stronger cash flow, and increased customer retention.Read more
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
R$23.92
4.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
13.72% p.a.
Profit Margin
3.7%
Future PE
29.69x
Share price in 2028
R$39.8
Digital Momentum And Demographic Shifts Will Drive Retail Health Expansion
Key Takeaways Accelerated digital transformation, AI integration, and a scaling marketplace platform are set to rapidly boost high-margin online sales, operational efficiency, and non-core revenue streams. Expansion into underpenetrated regions, rising customer loyalty, and demographic trends position the company for sustained market share gains and long-term earnings outperformance.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
R$28.54
19.8% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
18.78% p.a.
Profit Margin
3.37%
Future PE
34.93x
Share price in 2028
R$47.37
Accelerating E-Commerce Shift And Rapid Expansion Will Compress Margins
Key Takeaways Rising digital adoption and intense new competition may erode margins, limit sales growth, and threaten Raia Drogasil's traditional competitive advantages. Accelerated store expansion risks market saturation, lower revenue per location, and growing costs, undermining long-term profitability.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
R$14.5
57.8% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
12.42% p.a.
Profit Margin
3.39%
Future PE
20.76x
Share price in 2028
R$24.03
Recently Updated Narratives
AN
RADL3: Aging Population And Digital Transformation Will Lift Retail Performance
Fair Value: R$23.92 4.3% undervalued intrinsic discount
7 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Accelerating E-Commerce Shift And Rapid Expansion Will Compress Margins
Fair Value: R$14.5 57.8% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Momentum And Demographic Shifts Will Drive Retail Health Expansion
Fair Value: R$28.54 19.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Raia Drogasil S.A. Key Details
About RADL3
- Founded
- 1905
- Employees
- 69860
- CEO
- WebsiteView website
Raia Drogasil S.A. engages in the retail sale of medicines, perfumes, personal hygiene and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
